Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.240
-0.130 (-5.49%)
At close: Mar 24, 2026, 4:00 PM EDT
2.316
+0.076 (3.40%)
After-hours: Mar 24, 2026, 7:23 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $402.58 million as of March 24, 2026. Its market cap has increased by 622.40% in one year.
Market Cap
402.58M
Enterprise Value
329.03M
1-Year Change
622.40%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $402.58M, a decrease of -61.69%. That is a compound annual growth rate of -18.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 425.94M | 390.38% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 440.59M |
| Entrada Therapeutics | 439.89M |
| Shattuck Labs | 437.97M |
| YD Bio | 437.94M |
| Aclaris Therapeutics | 431.73M |
| REGENXBIO | 430.45M |
| Invivyd | 421.07M |
| Aura Biosciences | 414.68M |